Broadcast

Advancing Tricuspid Valve Replacement: Real-World Outcomes and Best…

Raj Makkar, Rebecca T Hahn, Fabien Praz, et al

Broadcast

Advancing Tricuspid Valve Replacement: Real-World Outcomes and Best…

Raj Makkar, Rebecca T Hahn, Fabien Praz, et al

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

Update on Transcatheter Options for TR Treatment

Published:

20 May 2019

Citation:

Interventional Cardiology Review 2019;14(2):54–61.

Improvement of Fractional Flow Reserve after Percutaneous Coronary Intervention Does Not Necessarily Indicate Increased Coronary Flow

Published:

30 April 2019

Citation:

European Cardiology Review 2019;14(1):10–2

Anomalous Coronary Arteries with a Malignant Course

Published:

20 May 2019

Citation:

Interventional Cardiology Review 2019;14(2):83–8.

Transcatheter Edge-to-edge Repair of Severe Tricuspid Regurgitation

Published:

12 March 2019

Citation:

US Cardiology Review 2019;13(1):35–40